DK161339C - Fremgangsmaade til fremstilling af et antibiotisk kompleks, omfattende erythromycin d og estere deraf, eller dets enkelte komponenter og mikroorganismekultur til anvendelse ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af et antibiotisk kompleks, omfattende erythromycin d og estere deraf, eller dets enkelte komponenter og mikroorganismekultur til anvendelse ved fremgangsmaaden

Info

Publication number
DK161339C
DK161339C DK158083A DK158083A DK161339C DK 161339 C DK161339 C DK 161339C DK 158083 A DK158083 A DK 158083A DK 158083 A DK158083 A DK 158083A DK 161339 C DK161339 C DK 161339C
Authority
DK
Denmark
Prior art keywords
procedure
sec
esters
erythromycin
micro
Prior art date
Application number
DK158083A
Other languages
Danish (da)
English (en)
Other versions
DK158083D0 (da
DK158083A (da
DK161339B (da
Inventor
Walter Daniel Celmer
Walter Patrick Cullen
Paul Colson Watts
Riichiro Shibakawa
Junsuke Tone
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK158083D0 publication Critical patent/DK158083D0/da
Publication of DK158083A publication Critical patent/DK158083A/da
Publication of DK161339B publication Critical patent/DK161339B/da
Application granted granted Critical
Publication of DK161339C publication Critical patent/DK161339C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/872Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK158083A 1982-04-12 1983-04-11 Fremgangsmaade til fremstilling af et antibiotisk kompleks, omfattende erythromycin d og estere deraf, eller dets enkelte komponenter og mikroorganismekultur til anvendelse ved fremgangsmaaden DK161339C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36782082 1982-04-12
US06/367,820 US4496546A (en) 1982-04-12 1982-04-12 Erythromycin D and esters thereof

Publications (4)

Publication Number Publication Date
DK158083D0 DK158083D0 (da) 1983-04-11
DK158083A DK158083A (da) 1983-10-13
DK161339B DK161339B (da) 1991-06-24
DK161339C true DK161339C (da) 1991-12-23

Family

ID=23448759

Family Applications (1)

Application Number Title Priority Date Filing Date
DK158083A DK161339C (da) 1982-04-12 1983-04-11 Fremgangsmaade til fremstilling af et antibiotisk kompleks, omfattende erythromycin d og estere deraf, eller dets enkelte komponenter og mikroorganismekultur til anvendelse ved fremgangsmaaden

Country Status (10)

Country Link
US (1) US4496546A (el)
EP (1) EP0092348B1 (el)
JP (3) JPS58198499A (el)
AT (1) ATE20604T1 (el)
CA (1) CA1194439A (el)
DE (1) DE3364348D1 (el)
DK (1) DK161339C (el)
ES (1) ES8404710A1 (el)
GR (1) GR78831B (el)
IE (1) IE54794B1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
JP2742054B2 (ja) * 1987-02-20 1998-04-22 北里研究所(社団法人) 動物の生長促進剤
JPH0733549U (ja) * 1993-12-09 1995-06-20 豊光産業株式会社 管材の研磨装置
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1176908A (fr) * 1953-06-02 1959-04-17 Abbott Lab Procédé de préparation d'antibiotiques du type de l'érythromycine
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4187292A (en) * 1977-03-31 1980-02-05 Takeda Chemical Industries, Ltd. Antibiotics produced from the microorganism nocardice
US4363803A (en) * 1982-03-01 1982-12-14 Pfizer Inc. 3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use

Also Published As

Publication number Publication date
CA1194439A (en) 1985-10-01
JPS61181373A (ja) 1986-08-14
ATE20604T1 (de) 1986-07-15
GR78831B (el) 1984-10-02
IE54794B1 (en) 1990-02-14
IE830816L (en) 1983-10-12
DK158083D0 (da) 1983-04-11
ES521321A0 (es) 1984-05-16
JPS61192298A (ja) 1986-08-26
EP0092348B1 (en) 1986-07-02
JPH0150398B2 (el) 1989-10-30
ES8404710A1 (es) 1984-05-16
JPS6235755B2 (el) 1987-08-04
DK158083A (da) 1983-10-13
DE3364348D1 (en) 1986-08-07
JPS58198499A (ja) 1983-11-18
JPS6363554B2 (el) 1988-12-07
EP0092348A1 (en) 1983-10-26
US4496546A (en) 1985-01-29
DK161339B (da) 1991-06-24

Similar Documents

Publication Publication Date Title
EP0311194A3 (en) Process for antifungal fermentation product and culture
IT1271001B (it) Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus
JPS56102793A (en) Preparation of antibiotic c-15003 p-3
DK161339C (da) Fremgangsmaade til fremstilling af et antibiotisk kompleks, omfattende erythromycin d og estere deraf, eller dets enkelte komponenter og mikroorganismekultur til anvendelse ved fremgangsmaaden
KR830007830A (ko) 엔듀라시딘 및 그를 위한 미생물의 제조방법
KR890008325A (ko) 아미노디옥시 만니톨의 제법
WO1988000200A3 (en) Process for the preparation of antibiotics 10381b
SE7711543L (sv) Forfarande for framstellning av maytansinol, maytanacin eller maytansinolpropionat
SE8402619L (sv) Nytt antibiotiskt antitumorkomplex och forfarande for framstellning derav
GB2019388A (en) Antibiotic DC-11 and process for production thereof
ES2059532T3 (es) Procedimiento microbiologico para la preparacion de uk-61.689 y microorganismos utiles para el mismo.
KR900006517A (ko) 항생제 pb-6042류
DE3169901D1 (en) Antibiotic am-5344-a2 and process for the preparation thereof
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
JPS5462392A (en) Preparation of antibiotic substance, sisomicin
FI102973B (fi) Menetelmä 17-oksosteroidien valmistamiseksi
JPS5543013A (en) Macrolide antibiotic n-1 and its preparation
JPS5462393A (en) Preparation of antibiotic substance, verdamicin
IE41079L (en) Antibiotics a-28086
JPS5716825A (en) Antibiotic ab-113 and its preparation
JPS5550896A (en) Preparation of antibiotic substance xk-62-5
SE7902005L (sv) Nytt forfarande for framstellning av cefamycin c
JPS5282795A (en) Preparation of novel antibiotics sf-1540
JPS57170190A (en) Novel antibiotic d-606 a and its preparation
JPS56154998A (en) Production of macrolide antibiotic through microbial conversion process

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed